Christina Ackermann - May 5, 2022 Form 3 Insider Report for Bausch & Lomb Corp (BLCO)

Role
Officer
Signature
/s/ Debra E. Levin, attorney-in-fact
Stock symbol
BLCO
Transactions as of
May 5, 2022
Transactions value $
$0
Form type
3
Date filed
5/5/2022, 06:33 PM
Previous filing
Mar 11, 2022
Next filing
Jun 3, 2022

No securities are beneficially owned.

Remarks:

The Reporting Person's title as an officer of the Issuer is Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals. Exhibit 24 - Power of Attorney